Subinhibitory concentration of kanamycin induces the Pseudomonas aeruginosa type VI secretion system

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Jones, Cerith ^a   Allsopp, Luke ^a   Horlick, Jack ^a   Kulasekara, Hemantha ^b   Filloux, Alain ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN; KANAMYCIN; TETRACYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; CULTURE MEDIUM;

AIRWAY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG CONCENTRATION; GENE CLUSTER; GENE EXPRESSION; INTRASPECIFIC COMPETITION; NONHUMAN; PSEUDOMONAS AERUGINOSA; SUBINHIBITORY CONCENTRATION; TOXIN SYNTHESIS; TYPE IV SECRETION SYSTEM; BACTERIAL SECRETION SYSTEM; BIOFILM; CULTURE MEDIUM; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; PLASMID; SIGNAL TRANSDUCTION;

ANTI-BACTERIAL AGENTS; BACTERIAL SECRETION SYSTEMS; BIOFILMS; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, BACTERIAL; KANAMYCIN; PLASMIDS; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION;

EID: 84892604631     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081132     Document Type: Article

References (64)

1. Jimenez PN, Koch G, Thompson JA, Xavier KB, Cool RH et al. (2012) The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 76: 46-65. doi:10.1128/MMBR.05007-11. PubMed: 22390972.
2. Rodrigue A, Quentin Y, Lazdunski A, Méjean V, Foglino M (2000) Two-component systems in Pseudomonas aeruginosa: why so many? Trends Microbiol 8: 498-504. doi:10.1016/S0966-842X(00)01833-3. PubMed: 11121759.
3. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P et al. (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406: 959-964. doi:10.1038/35023079. PubMed: 10984043.
4. Ringen LM, Drake CH (1952) A study of the incidence of Pseudomonas aeruginosa from various natural sources. J Bacteriol 64: 841-845. PubMed: 13011158.
5. Driscoll JA, Brody SL, Kollef MH (2007) The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67: 351-368. doi:10.2165/00003495-200767030-00003. PubMed: 17335295.
6. Strateva T, Markova B, Markovska R, Marteva-Proevska Y, Ivanova D et al. (2011) Emergence of 16s rRNA methylase-producing nosocomial Acinetobacter baumannii isolates in a university hospital in Bulgaria. J Chemother 23: 374-375. PubMed: 22233825.
7. Mann EE, Wozniak DJ (2012) Pseudomonas biofilm matrix composition and niche biology. FEMS Microbiol Rev 36: 893-916. doi:10.1111/j.1574-6976.2011. 00322.x. PubMed: 22212072.
8. Coggan KA, Wolfgang MC (2012) Global regulatory pathways and cross-talk control pseudomonas aeruginosa environmental lifestyle and virulence phenotype. Curr Issues Mol Biol 14: 47-70. PubMed: 22354680.
9. Mikkelsen H, Sivaneson M, Filloux A (2011) Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa. Environ Microbiol 13: 1666-1681. doi:10.1111/j.1462-2920.2011.02495.x. PubMed: 21554516.
10. Harmsen M, Yang L, Pamp SJ, Tolker-Nielsen T (2010) An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal. FEMS Immunol Med Microbiol 59: 253-268. PubMed: 20497222.
11. Hoffman LR, D'Argenio DA, MacCoss MJ, Zhang Z, Jones RA et al. (2005) Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436: 1171-1175. doi:10.1038/nature03912. PubMed: 16121184.
12. Gotoh H, Zhang Y, Dallo SF, Hong S, Kasaraneni N et al. (2008) Pseudomonas aeruginosa, under DNA replication inhibition, tends to form biofilms via Arr. Res Microbiol 159: 294-302. doi:10.1016/j.resmic.2008.02.002. PubMed: 18434096.
13. Linares JF, Gustafsson I, Baquero F, Martinez JL (2006) Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci U S A 103: 19484-19489. doi:10.1073/pnas.0608949103. PubMed: 17148599.
14. Mills E, Pultz IS, Kulasekara HD, Miller SI (2011) The bacterial second messenger c-di-GMP: mechanisms of signalling. Cell Microbiol 13: 1122-1129. doi:10.1111/j.1462-5822.2011.01619.x. PubMed: 21707905.
15. Römling U, Galperin MY, Gomelsky M (2013) Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol Mol Biol Rev 77: 1-52. doi:10.1128/MMBR.masthead.77-2. PubMed: 23471616.
16. Bordi C, Lamy MC, Ventre I, Termine E, Hachani A et al. (2010) Regulatory RNAs and the HptB/RetS signalling pathways fine-tune Pseudomonas aeruginosa pathogenesis. Mol Microbiol 76: 1427-1443. doi:10.1111/j.1365-2958.2010.07146.x. PubMed: 20398205.
17. Goodman AL, Kulasekara B, Rietsch A, Boyd D, Smith RS et al. (2004) A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev Cell 7: 745-754. doi:10.1016/j.devcel.2004.08.020. PubMed: 15525535.
18. Goodman AL, Merighi M, Hyodo M, Ventre I, Filloux A et al. (2009) Direct interaction between sensor kinase proteins mediates acute and chronic disease phenotypes in a bacterial pathogen. Genes Dev 23: 249-259. doi:10.1101/gad. 1739009. PubMed: 19171785.
19. Lapouge K, Schubert M, Allain FH, Haas D (2008) Gac/Rsm signal transduction pathway of gamma-proteobacteria: from RNA recognition to regulation of social behaviour. Mol Microbiol 67: 241-253. PubMed: 18047567.
20. Laskowski MA, Kazmierczak BI (2006) Mutational analysis of RetS, an unusual sensor kinase-response regulator hybrid required for Pseudomonas aeruginosa virulence. Infect Immun 74: 4462-4473. doi:10.1128/IAI.00575-06. PubMed: 16861632.
21. Ventre I, Goodman AL, Vallet-Gely I, Vasseur P, Soscia C et al. (2006) Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. Proc Natl Acad Sci U S A 103: 171-176. doi:10.1073/pnas.0507407103. PubMed: 16373506.
22. Hauser AR (2009) The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 7: 654-665. doi:10.1038/nrmicro2199. PubMed: 19680249.
23. Filloux A, Hachani A, Bleves S (2008) The bacterial type VI secretion machine: yet another player for protein transport across membranes. Microbiology 154: 1570-1583. doi:10.1099/mic.0.2008/016840-0. PubMed: 18524912.
24. Hood RD, Singh P, Hsu F, Güvener T, Carl MA et al. (2010) A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe 7: 25-37. doi:10.1016/j.chom.2009.12.007. PubMed: 20114026.
25. LeRoux M, De Leon JA, Kuwada NJ, Russell AB, Pinto-Santini D et al. (2012) Quantitative single-cell characterization of bacterial interactions reveals type VI secretion is a double-edged sword. Proc Natl Acad Sci U S A 109: 19804-19809. doi:10.1073/pnas.1213963109. PubMed: 23150540.
26. Russell AB, Hood RD, Bui NK, LeRoux M, Vollmer W et al. (2011) Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475: 343-347. doi:10.1038/nature10244. PubMed: 21776080.
27. Russell AB, Singh P, Brittnacher M, Bui NK, Hood RD et al. (2012) A widespread bacterial type VI secretion effector superfamily identified using a heuristic approach. Cell Host Microbe 11: 538-549. doi:10.1016/j.chom.2012.04. 007. PubMed: 22607806.
28. Rybtke MT, Borlee BR, Murakami K, Irie Y, Hentzer M et al. (2012) Fluorescence-based reporter for gauging cyclic di-GMP levels in Pseudomonas aeruginosa. Appl Environ Microbiol 78: 5060-5069. doi:10.1128/AEM.00414-12. PubMed: 22582064.
29. Hachani A, Lossi NS, Hamilton A, Jones C, Bleves S et al. (2011) Type VI secretion system in Pseudomonas aeruginosa: secretion and multimerization of VgrG proteins. J Biol Chem 286: 12317-12327. doi:10.1074/jbc.M110.193045. PubMed: 21325275.
30. Vasseur P, Vallet-Gely I, Soscia C, Genin S, Filloux A (2005) The pel genes of the Pseudomonas aeruginosa PAK strain are involved at early and late stages of biofilm formation. Microbiology 151: 985-997. doi:10.1099/mic.0.27410- 0. PubMed: 15758243.
31. Kaniga K, Delor I, Cornelis GR (1991) A wide-host-range suicide vector for improving reverse genetics in gram-negative bacteria: inactivation of the blaA gene of Yersinia enterocolitica. Gene 109: 137-141. doi:10.1016/0378- 1119(91)90599-7. PubMed: 1756974.
32. Hachani A, Lossi NS, Filloux A (2013) A visual assay to monitor T6SS-mediated bacterial competition. J Vis Exp: e50103. PubMed: 23542679.
33. Miller JH (1992) A short course in bacterial genetics: A laboratory manual and handbook for Escherichia coli and related bacteria.
34. Kulasakara H, Lee V, Brencic A, Liberati N, Urbach J et al. (2006) Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3′-5′)-cyclic-GMP in virulence. Proc Natl Acad Sci U S A 103: 2839-2844. doi:10.1073/pnas.0511090103. PubMed: 16477007.
35. Moscoso JA, Mikkelsen H, Heeb S, Williams P, Filloux A (2011) The Pseudomonas aeruginosa sensor RetS switches type III and type VI secretion via c-di-GMP signalling. Environ Microbiol 13: 3128-3138. doi:10.1111/j.1462-2920. 2011.02595.x. PubMed: 21955777.
36. Mougous JD, Cuff ME, Raunser S, Shen A, Zhou M et al. (2006) A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science 312: 1526-1530. doi:10.1126/science.1128393. PubMed: 16763151.
37. Brencic A, McFarland KA, McManus HR, Castang S, Mogno I et al. (2009) The GacS/GacA signal transduction system of Pseudomonas aeruginosa acts exclusively through its control over the transcription of the RsmY and RsmZ regulatory small RNAs. Mol Microbiol 73: 434-445. doi:10.1111/j.1365-2958.2009.06782.x. PubMed: 19602144.
38. Brencic A, Lory S (2009) Determination of the regulon and identification of novel mRNA targets of Pseudomonas aeruginosa RsmA. Mol Microbiol 72: 612-632. doi:10.1111/j.1365-2958.2009.06670.x. PubMed: 19426209.
39. Mikkelsen H, McMullan R, Filloux A (2011) The Pseudomonas aeruginosa reference strain PA14 displays increased virulence due to a mutation in ladS. PLOS ONE 6: e29113. doi:10.1371/journal.pone.0029113. PubMed: 22216178.
40. Lossi NS, Manoli E, Förster A, Dajani R, Pape T et al. (2013) The HsiB1C1 (TssB-TssC) complex of the Pseudomonas aeruginosa type VI secretion system forms a bacteriophage tail sheathlike structure. J Biol Chem 288: 7536-7548. doi:10.1074/jbc.M112.439273. PubMed: 23341461.
41. Brinkman FS, Macfarlane EL, Warrener P, Hancock RE (2001) Evolutionary relationships among virulence-associated histidine kinases. Infect Immun 69: 5207-5211. doi:10.1128/IAI.69.8.5207-5211.2001. PubMed: 11447209.
42. Bleves S, Soscia C, Nogueira-Orlandi P, Lazdunski A, Filloux A (2005) Quorum sensing negatively controls type III secretion regulon expression in Pseudomonas aeruginosa PAO1. J Bacteriol 187: 3898-3902. doi:10.1128/JB.187.11. 3898-3902.2005. PubMed: 15901720.
43. Hilbi H, Weber SS, Ragaz C, Nyfeler Y, Urwyler S (2007) Environmental predators as models for bacterial pathogenesis. Environ Microbiol 9: 563-575. doi:10.1111/j.1462-2920.2007.01238.x. PubMed: 17298357.
44. Bjarnsholt T, Givskov M (2007) The role of quorum sensing in the pathogenicity of the cunning aggressor Pseudomonas aeruginosa. Anal Bioanal Chem 387: 409-414. doi:10.1007/s00216-006-0774-x. PubMed: 17019573.
45. Wolfgang MC, Lee VT, Gilmore ME, Lory S (2003) Coordinate regulation of bacterial virulence genes by a novel adenylate cyclase-dependent signaling pathway. Dev Cell 4: 253-263. doi:10.1016/S1534-5807(03)00019-4. PubMed: 12586068.
46. Girard G, Bloemberg GV (2008) Central role of quorum sensing in regulating the production of pathogenicity factors in Pseudomonas aeruginosa. Future Microbiol 3: 97-106. doi:10.2217/17460913.3.1.97. PubMed: 18230038.
47. Byrd MS, Pang B, Hong W, Waligora EA, Juneau RA et al. (2011) Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection model. Infect Immun 79: 3087-3095. doi:10.1128/IAI.00057-11. PubMed: 21646454.
48. Lory S, Merighi M, Hyodo M (2009) Multiple activities of c-di-GMP in Pseudomonas aeruginosa. Nucleic Acids Symp Ser (Oxf): 51-52. PubMed: 19749255.
49. Petrova OE, Sauer K (2009) A novel signaling network essential for regulating Pseudomonas aeruginosa biofilm development. PLOS Pathog 5: e1000668.
50. Liberati NT, Urbach JM, Miyata S, Lee DG, Drenkard E et al. (2006) An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci U S A 103: 2833-2838. doi:10.1073/pnas. 0511100103. PubMed: 16477005.
51. Roy PH, Tetu SG, Larouche A, Elbourne L, Tremblay S et al. (2010) Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7. PLOS ONE 5: e8842. doi:10.1371/journal.pone.0008842. PubMed: 20107499.
52. Jing X, Jaw J, Robinson HH, Schubot FD (2010) Crystal structure and oligomeric state of the RetS signaling kinase sensory domain. Proteins 78: 1631-1640. PubMed: 20112417.
53. Vincent F, Round A, Reynaud A, Bordi C, Filloux A et al. (2010) Distinct oligomeric forms of the Pseudomonas aeruginosa RetS sensor domain modulate accessibility to the ligand binding site. Environ Microbiol 12: 1775-1786. PubMed: 20553556.
54. Hocquet D, Llanes C, Thouverez M, Kulasekara HD, Bertrand X et al. (2012) Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting. PLOS Pathog 8: e1002778.
55. Mikkelsen H, Swatton JE, Lilley KS, Welch M (2010) Proteomic analysis of the adaptive responses of Pseudomonas aeruginosa to aminoglycoside antibiotics. FEMS Microbiol Lett. PubMed: 21204916
56. Irie Y, Starkey M, Edwards AN, Wozniak DJ, Romeo T et al. (2010) Pseudomonas aeruginosa biofilm matrix polysaccharide Psl is regulated transcriptionally by RpoS and post-transcriptionally by RsmA. Mol Microbiol 78: 158-172. PubMed: 20735777.
57. Heurlier K, Williams F, Heeb S, Dormond C, Pessi G et al. (2004) Positive control of swarming, rhamnolipid synthesis, and lipase production by the posttranscriptional RsmA/RsmZ system in Pseudomonas aeruginosa PAO1. J Bacteriol 186: 2936-2945. doi:10.1128/JB.186.10.2936-2945.2004. PubMed: 15126453.
58. Zin NZ, Tasrip NA, Desa MN, Kqueen CY, Zakaria ZA et al. (2011) Characterization and antimicrobial activities of two Streptomyces isolates from soil in the periphery of Universiti Putra Malaysia. Trop Biomed 28: 651-660. PubMed: 22433896.
59. Baron SS, Rowe JJ (1981) Antibiotic action of pyocyanin. Antimicrob Agents Chemother 20: 814-820. doi:10.1128/AAC.20.6.814. PubMed: 6798928.
60. Casabona MG, Silverman JM, Sall KM, Boyer F, Couté Y et al. (2013) An ABC transporter and an outer membrane lipoprotein participate in posttranslational activation of type VI secretion in Pseudomonas aeruginosa. Environ Microbiol 15: 471-486. doi:10.1111/j.1462-2920.2012.02816.x. PubMed: 22765374.
61. Kulasekara HD, Miller SI (2007) Threonine phosphorylation times bacterial secretion. Nat Cell Biol 9: 734-736. doi:10.1038/ncb0707-734. PubMed: 17603507.
62. Mougous JD, Gifford CA, Ramsdell TL, Mekalanos JJ (2007) Threonine phosphorylation post-translationally regulates protein secretion in Pseudomonas aeruginosa. Nat Cell Biol 9: 797-803. doi:10.1038/ncb1605. PubMed: 17558395.
63. Basler M, Ho BT, Mekalanos JJ (2013) Tit-for-tat: type VI secretion system counterattack during bacterial cell-cell interactions. Cell 152: 884-894. doi:10.1016/j.cell.2013.01.042. PubMed: 23415234.
64. Figurski DH, Helinski DR (1979) Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci U S A 76: 1648-1652. doi:10.1073/pnas.76.4.1648. PubMed: 377280.